Uspstandard Astragalus Extract Boosts Pharma Quality Control

Astragalus, a traditional herb with a long history of medicinal use, has gained increasing scientific attention for its therapeutic potential. Modern research indicates that astragalus contains numerous bioactive compounds including astragalus polysaccharides, astragalosides (such as astragaloside IV), and flavonoids (including calycosin and formononetin). These components demonstrate significant pharmacological effects in immune modulation, antioxidant activity, anti-inflammatory responses, and cardiovascular protection.

However, the concentration of active ingredients in astragalus varies due to factors like geographical origin, harvest time, processing methods, and extraction techniques, presenting challenges for standardization and quality control.

As a globally recognized pharmacopeial authority, USP reference standards undergo rigorous validation to ensure accuracy and reliability. The new Astragalus Root Dry Extract Reference Standard serves as a benchmark for analytical testing, enabling researchers and quality control professionals to:

• Assess raw material quality: Verify that astragalus materials meet established quality specifications with adequate active ingredient content.
• Monitor manufacturing processes: Validate production methods and conduct in-process controls to ensure product consistency.
• Verify finished product quality: Perform content analysis and impurity profiling to confirm compliance with pharmacopeial and regulatory standards.
• Support drug development: Provide essential quality control measures for developing new astragalus-based medications or improving existing formulations.

The newly released USP Astragalus Root Dry Extract Reference Standard (1g, Catalog #1044119) is currently available for $198.00. Classified as a Reference Standard, the product is packaged in glass vials for convenient storage and handling. The batch number F01440 comes with current USP certification.

According to USP documentation, the material originates from China, maintaining its original botanical source. USP notes that while materials are sourced globally, most foreign-sourced materials undergo no fundamental changes during USP packaging processes. For plant-derived materials, USP recommends users consult local authorities regarding potential import requirements.

• Formononetin (50 mg) - Catalog #1286060 for isoflavone analysis
• Ononin (50 mg) - Catalog #1478651 for isoflavone glycoside studies
• Astragaloside IV (100 mg) - Catalog #1044108 for key saponin quantification
• Calycosin (50 mg) - Catalog #1087472 for flavonoid analysis
• Calycosin 7-O-beta-D-Glucopyranoside (50 mg) - Catalog #1087483 for glycoside studies

These standards facilitate precise quantification of specific bioactive compounds and support analytical method development using techniques like HPLC and TLC. Accurate measurement of these markers enhances understanding of astragalus's pharmacological mechanisms, optimizes extraction processes, and establishes scientific quality standards.

The introduction of USP's Astragalus Root Dry Extract Reference Standard represents a significant advancement for global pharmaceutical quality control. As interest in botanical medicines grows alongside increasing demands for product safety and efficacy, pharmacopeial standards will continue to play a vital role in the field.

Future developments may include expanded astragalus reference materials covering additional bioactive compounds and quality markers, further supporting international standardization efforts and unlocking the full therapeutic potential of this traditional herb.